Author: Deal Street Asia Online News

China’s Maison Capital closes fifth RMB-denominated fund at $231m

Maison Capital, an investment firm that has backed Chinese drone giant DJI, has closed an oversubscribed, new RMB-denominated fund at about 1.5 billion yuan ($231.4 million), it announced on Thursday. The new fund will help Maison Capital double down on growth-stage enterprises in the fields of healthcare, advanced technology, and consumption upgrade. The fund, Maison… Continue reading China’s Maison Capital closes fifth RMB-denominated fund at $231m

China said to plan ban on US listings of tech firms with data security risks

China is framing rules to ban internet companies whose data poses potential security risks from listing outside the country, including in the United States, according to a person familiar with the matter. The ban is also expected to be imposed on companies involved in ideology issues, said the person, declining to be identified as the… Continue reading China said to plan ban on US listings of tech firms with data security risks

Indian VC firm A91 Partners secures final close of second fund at $525m: Report

Venture capital firm A91 Partners, floated by former Sequoia Capital executives, has reportedly reached the final close of its second fund by garnering $525 million in capital commitments. The sponsors or limited partners in the fund include the Canada Pension Plan Investment Board and financial services major Allianz group, The Economic Times reported. The firm… Continue reading Indian VC firm A91 Partners secures final close of second fund at $525m: Report

LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals

Clinical stage drug maker Lynk Pharmaceuticals Co. has completed a Series B round of financing, raising as much as $50 million, led by the Shanghai-based venture capital firm Lilly Asia Ventures (LAV), the investor announced on Friday.  New investors New Alliance Capital and Hangzhou Heda Industry Fund participated in the round, while returning investors Legend… Continue reading LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals

PE firm Everstone prepares to exit India’s Sahyadri Hospitals

Private equity firm Everstone has initiated the process to exit Sahyadri Hospitals two years after backing the institution. It is targeting an internal rate of return (IRR) of 50-60%. Private equity and venture capital firms typically look at a 5-6 year investment horizon and target an IRR of 20-30%. Seven to eight investors have shown… Continue reading PE firm Everstone prepares to exit India’s Sahyadri Hospitals

Asia Digest: Australia-listed Appen buys SG’s Quadrant; PEP invites bids for Intellihub …

ASX-listed data company Appen announced that it has acquired Singapore-based mobile-location data firm Quadrant, while Australia-based Pacific Equity Partners (PEP) has launched bids for Intellihub with a deadline of September 27. Appen buys Quadrant in cash and shares ASX-listed data company Appen has acquired the Singapore-based mobile-location data firm Quadrant. Appen will make an upfront… Continue reading Asia Digest: Australia-listed Appen buys SG’s Quadrant; PEP invites bids for Intellihub …

New York City approves licences, price controls for food-delivery apps

The New York City Council on Thursday approved legislation to license food-delivery apps including Grubhub, DoorDash Inc and Uber Eats and to permanently cap commissions they can charge restaurants. The companies say the price controls are unfair and vowed to fight them. “This permanent price control is flagrantly unconstitutional and will hurt local restaurants, delivery workers and diners across… Continue reading New York City approves licences, price controls for food-delivery apps

China Deal Review: Unfazed by regulatory action, PE-VC funding rises 11.6% to $7b in July …

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to… Continue reading China Deal Review: Unfazed by regulatory action, PE-VC funding rises 11.6% to $7b in July …